Skip to main content

Bone Biologics Corp

For the period ended Dec 31, 2025. Filed Mar 2, 2026.

View on SEC.gov

About this filing

A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.

FY2025 · Filed Mar 2, 2026

BBLG$0.33+3.0%Stored close · as of Nov 6, 2026

Extracted filing text, with the paragraph anchors used by the comparison.

See the whole filing, with its images and exhibits
Contents

Power of Attorney

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Jeffrey Frelick and Deina H. Walsh, and each of them, as his true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for him and in his name, place, and stead, in any and all capacities, to sign any and all amendments to this Annual Report on Form 10-K and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith as fully to all intents and purposes as he might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents, or any of them, or their or his substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Exchange Act of 1934, this report has been signed by the following persons in the capacities and on the dates indicated.

SignatureTitleDate
/s/ Jeffrey Frelick
Jeffrey FrelickChief Executive Officer (Principal Executive Officer)March 2, 2026
/s/ Deina H. Walsh
Deina H. WalshChief Financial Officer (Principal Financial Officer and Principal Accounting Officer)March 2, 2026
/s/ Bruce Stroever
Bruce StroeverDirectorMarch 2, 2026
/s/ Robert Gagnon
Robert GagnonDirectorMarch 2, 2026
/s/ Siddhesh Angle
Siddhesh AngleDirectorMarch 2, 2026
/s/ Phillip Meikle
Phillip MeikleDirectorMarch 2, 2026
ContentsView on SEC.gov

The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.